Safe Prescribing of Anti-Obesity Medications for APRNs

This 3-contact hour continuing education course is designed for advanced practice registered nurses (APRNs) who prescribe pharmacologic therapies for obesity. With obesity now classified as a chronic disease, pharmacotherapy is increasingly used as an adjunct to lifestyle interventions. This course provides a comprehensive, evidence-based overview of the current anti-obesity medications approved for adult use, with an emphasis on safe prescribing, individualized patient selection, therapeutic monitoring, and adverse effect management. Content will explore glucagon-like peptide-1 (GLP-1) receptor agonists, dual agonists, and other FDA-approved agents, focusing on clinical efficacy, contraindications, monitoring parameters, and real-world prescribing considerations. APRNs will gain the knowledge needed to integrate obesity medications safely and effectively into patient care, aligned with current clinical guidelines and scope of practice regulations.